Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
-18.43%
08.11.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€29.80
07.09.22
€50.00
31.12.25
9.40%
08.07.24

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.91
13.08.22
€1.00
13.08.23
-12.70%
23.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€2.68
27.06.22
-
27.06.23
-12.04%
23.10.22

Could be worthwhile Investment >10% per year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.24
24.06.22
€5.00
24.06.23
-1.57%
26.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€2.91
15.06.22
-
15.06.23
8.65%
09.07.22

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.77
10.06.22
€0.20
10.06.23
24.58%
26.06.22

Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€7.76
14.05.22
-
14.05.23
-4.60%
28.05.22

Risky Investment
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

Inotiv Inc.

Start price
Target price
Perf. (%)
€13.40
01.05.22
-
01.05.23
-63.13%
24.04.23

Probably not worthwhile Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.54
07.04.22
-
07.04.23
-9.24%
18.04.22

Risky Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€16.30
06.04.22
€4.00
06.04.23
-13.48%
18.04.22

Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€7.59
01.04.22
€12.50
01.04.23
-76.56%
04.03.23

Could be worthwhile Investment >10% per year
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€8.50
30.03.22
-
30.03.23
-24.12%
31.03.22

Risky Investment
Lipocine Inc.

Start price
Target price
Perf. (%)
€28.44
29.03.22
-
29.03.23
-28.90%
02.04.22

Risky Investment
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€21.16
28.03.22
-
28.03.23
-9.86%
02.04.22

Risky Investment
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.20
06.03.22
-
06.03.23
17.35%
17.03.22

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.70
07.02.22
-
07.02.23
-60.50%
19.09.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€12.78
24.01.22
-
24.01.23
22.85%
07.02.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment